Aspide Surgimesh Lawsuit Update: Injuries, Recall Status, and Legal Options

The U.S. Food and Drug Administration (FDA) recognizes risks associated with hernia mesh, including adhesions, bowel obstruction, infection, and mesh migration. Federal records also document four limited Surgimesh recalls involving possible residual adhesive material on the mesh surface.

Patients who developed serious complications after receiving Surgimesh may have grounds for an individualized product-liability evaluation. However, a postoperative complication does not automatically establish that the implanted mesh was defective or that its manufacturer is legally responsible.

Quick Facts

• Product: Aspide Surgimesh surgical mesh, including WN, XB, and XD product lines.
• Manufacturer: Aspide Medical; BG Medical was identified as a U.S. distributor in federal litigation.
• Potential complications: Chronic pain, infection, adhesions, bowel obstruction, mesh migration, and hernia recurrence.
• Recall status: Four completed Class II recalls involving 110 Surgimesh WN and XB units over possible residual adhesive material.

Latest News on the Aspide Surgimesh Lawsuit

November 2026

A November 10, 2026 review of FDA medical device records confirms four completed Class II recalls involving specific Surgimesh WN and XB product lots. The FDA identifies possible residual adhesive material on the mesh surface as the reason for the recalls [1].

The affected products were recalled by Chamberlain Technologies LLC, with customer notifications beginning August 12, 2022. The FDA posted the recall entries on June 17, 2025, and identifies 110 units in commerce across the four entries.

The November review also examined federal multidistrict litigation statistics and Surgimesh-specific court records. A September 1, 2026 Judicial Panel on Multidistrict Litigation report listed 23,316 pending lawsuits involving Davol and C.R. Bard polypropylene hernia mesh products [2].

Those lawsuits involve different manufacturers and do not establish claims against Aspide Medical. The reviewed records did not establish a nationwide Surgimesh settlement or new Surgimesh-specific multidistrict litigation proceeding.

The FDA continues to identify pain, infection, adhesions, bowel obstruction, mesh migration, and contraction among complications associated with hernia repair and implanted mesh [3].

June 2025

On June 17, 2025, the FDA posted four Class II recall records involving Surgimesh products. All four actions involved potential residual adhesive contamination and were initiated on August 12, 2022.

The affected products included:

• Surgimesh WN T3030: Large flat sheet, lot Z2459757F, 60 units; recall Z-1983-2025.
• Surgimesh WN T1415: 14 cm by 15 cm flat sheet, lot Z2459757H, 20 units; recall Z-1986-2025 [4].
• Surgimesh XB Tintra E-3030: Extra-large ellipse barrier mesh, lot Z2459757G, 10 units; recall Z-1985-2025 [5].
• Surgimesh XB Tintra R-1415: Flat sheet with silicone barrier, lot Z2459695M, 20 units; recall Z-1984-2025 [6].

The FDA identifies distribution to Illinois, Nebraska, and California. Customers were instructed to segregate affected products and return them to BG Medical.

All four recall entries are marked completed. They do not establish that every affected unit was implanted or that residual adhesive caused injuries in specific patients.

August 2019

On August 8, 2019, the U.S. District Court for the Southern District of California issued an order in Billedeaux v. Surgimesh/Aspide Medical and BG Medical. The plaintiff alleged pain, seroma, scarring, mesh migration, and additional surgery following hernia mesh implantation [7].

The court denied BG Medical’s motion to dismiss, allowing the challenged claims to proceed. The ruling did not determine that Surgimesh was defective, establish causation, or award damages.

April 2019

On April 16, 2019, the FDA ordered manufacturers to stop selling surgical mesh intended for transvaginal repair of pelvic organ prolapse. The agency determined that the manufacturers had not demonstrated reasonable assurance of safety and effectiveness for those devices [8].

The restriction concerned transvaginal pelvic-organ-prolapse mesh, not surgical mesh used for hernia repair generally. It did not constitute an FDA ban on Aspide Surgimesh.

February 2007

The FDA cleared Surgimesh WN under 510(k) number K061445 on February 1, 2007. The clearance identified the device as polymeric surgical mesh and found it substantially equivalent to a legally marketed predicate device [9].

The FDA subsequently cleared Surgimesh XB on August 18, 2008, under K072974, and Surgimesh XD on June 25, 2010, under K092233 [10] [11].

FDA clearance permits marketing for an authorized intended use but does not guarantee that an implant cannot cause complications.

Event	Month/Year	Type	Status	Source	Notes
Surgimesh recall status review	November 2026	Regulatory review	Reviewed	[1]	Four completed recalls verified
Federal hernia mesh litigation review	September 2026	Litigation statistics	Published	[2]	Separate Bard litigation
Four Surgimesh recalls posted	June 2025	Medical device recall	Completed	[1]	110 units across four lots
Surgimesh court ruling	August 2019	Product-liability litigation	Motion denied	[7]	No liability finding
FDA transvaginal mesh restriction	April 2019	Regulatory action	Sales stopped	[8]	Not a hernia mesh ban
Surgimesh XD clearance	June 2010	FDA clearance	Cleared	[11]	510(k) K092233
Surgimesh XB clearance	August 2008	FDA clearance	Cleared	[10]	510(k) K072974
Surgimesh WN clearance	February 2007	FDA clearance	Cleared	[9]	510(k) K061445

What Is Aspide Surgimesh?

Surgimesh is a line of implantable surgical mesh products developed by Aspide Medical, a French medical device manufacturer. The products are used for soft-tissue reinforcement, including hernia repair.

Surgical mesh helps strengthen weakened tissue and reduce hernia recurrence. Depending on the procedure and implant, surgeons may place mesh through open, laparoscopic, or other surgical approaches.

Aspide’s Surgimesh line includes several configurations with different materials and designs.

Surgimesh WN

Surgimesh WN is a nonwoven, nonknitted polypropylene surgical mesh intended to provide permanent tissue reinforcement. FDA records identify its clearance under K061445.

Surgimesh XB

Surgimesh XB incorporates polypropylene reinforcement with a silicone barrier. The barrier is intended to reduce unwanted tissue attachment where contact with internal structures may occur.

Surgimesh XD

Surgimesh XD is a separate polymeric surgical mesh device cleared under FDA 510(k) K092233. Its specifications and intended surgical use should be confirmed from the product’s labeling and operative records.

These configurations should not be treated as interchangeable when determining whether an implant was recalled or allegedly defective.

What’s the Problem With Surgical Mesh?

Surgical mesh can provide durable reinforcement, but implantation carries potential complications. Problems may arise from surgical technique, infection, tissue response, underlying health conditions, or the implanted device.

The FDA identifies several complications associated with hernia repair, including pain, infection, recurrence, adhesions, bowel obstruction, and perforation. Mesh-specific complications can include migration and contraction.

Chronic Pain and Inflammation

Persistent abdominal or groin pain may result from nerve irritation, scar tissue, inflammation, recurrence, or complications involving implanted mesh. Symptoms sometimes require specialist evaluation or further treatment.

Infection

Infection can develop around the surgical site or implanted material. Persistent infections may require antibiotics, drainage, additional surgery, or removal of infected mesh.

Adhesions and Bowel Obstruction

Adhesions are scar-like tissue bands that can cause internal structures to stick together. Severe adhesions may contribute to intestinal obstruction, abdominal pain, or additional surgery.

Mesh Migration and Contraction

Migration occurs when mesh moves from its intended position. Contraction or shrinkage may alter surrounding tissue and contribute to discomfort or mechanical complications.

Hernia Recurrence

A hernia can return after surgical repair, with or without mesh. Recurrence may require evaluation and sometimes another operation.

These are recognized complications of hernia repair and surgical mesh generally. They are not verified incidence rates or established findings of defect involving every Surgimesh model.

What Does the FDA Say About Surgical Mesh Risks?

The FDA acknowledges that surgical mesh can reduce the likelihood of hernia recurrence compared with certain non-mesh repairs. Nevertheless, the agency emphasizes that mesh implantation carries risks requiring individualized surgical assessment.

Recognized complications include infection, chronic pain, adhesions, obstruction, fistula, seroma, bleeding, and perforation. Mesh migration and contraction may contribute to additional problems.

The FDA has not imposed a general ban on mesh used for hernia repair. Its 2019 sales restriction concerned transvaginal mesh for pelvic-organ-prolapse repair, a different medical application.

Were Aspide Surgimesh Products Recalled?

Yes. The FDA documents four limited Class II recalls involving specific Surgimesh WN and XB lots because of possible residual adhesive material.

Chamberlain Technologies LLC was the recalling firm, and the affected products were distributed in Illinois, Nebraska, and California. Customers were instructed to segregate and return affected inventory to BG Medical.

The recalls collectively involved 110 units and are listed as completed. FDA records do not establish that all affected units were implanted or that every Surgimesh product was defective.

Patients concerned about an implant should obtain the operative report and product identification records. Catalog numbers, lot numbers, and unique device identifiers can help establish whether the implanted mesh was included.

Are There Aspide Surgimesh Lawsuits?

Yes. Federal court records document litigation involving Surgimesh, Aspide Medical, and BG Medical.

In Billedeaux v. Surgimesh, the plaintiff alleged complications following hernia mesh implantation, including pain, seroma, scarring, migration, and additional surgery. The complaint included product-liability allegations concerning the implanted device.

On August 8, 2019, the court denied BG Medical’s motion to dismiss. The ruling addressed whether the plaintiff’s allegations were legally sufficient to proceed, not whether the allegations were proven.

Other manufacturers face substantial hernia mesh litigation, including Davol and C.R. Bard in MDL 2846. Those lawsuits are separate from Surgimesh and do not establish a nationwide Aspide settlement.

Could Aspide Medical Be Liable for Surgimesh Injuries?

Patients may pursue product-liability claims when evidence supports allegations that defective surgical mesh caused an injury. Depending on applicable law, potential theories include manufacturing defects, inadequate warnings, defective design, negligence, or breach of warranty.

Potentially responsible parties may include manufacturers, distributors, or other companies involved in supplying the device. Claims generally require evidence concerning the implant, alleged defect, medical causation, and resulting damages.

FDA clearance, a recall, or the existence of litigation does not automatically establish liability in an individual case.

Who May Be Affected by Surgimesh Complications?

Patients who received Surgimesh during hernia repair and subsequently developed serious complications may have grounds for individualized legal review.

Relevant conditions include chronic pain, infection, adhesions, bowel obstruction, mesh migration, recurrence, and complications requiring revision surgery.

Patients without symptoms should not assume that their implant requires removal solely because certain Surgimesh lots were recalled. Medical treatment decisions should be discussed with a qualified healthcare professional.

Do I Qualify for an Aspide Surgimesh Lawsuit?

The following questions may help determine whether a potential claim warrants further legal evaluation:

• Were you implanted with Aspide Surgimesh during hernia repair or another surgical procedure?
• Did you develop chronic pain, infection, mesh migration, adhesions, bowel obstruction, or another serious complication?
• Did the condition require hospitalization, revision surgery, mesh removal, or substantial additional treatment?
• Do you have operative reports, implant identification records, medical documentation, or other supporting evidence?

Answering yes does not establish eligibility or guarantee compensation. An attorney can evaluate the implanted product, medical causation, damages, potential defendants, and applicable filing deadlines.

What Evidence Is Important in a Surgimesh Lawsuit?

Identifying the implanted mesh is particularly important because the documented recalls affected specific Surgimesh lots rather than the entire product line.

Relevant documentation may include:

• Original surgical and operative reports
• Implant identification stickers and hospital records
• Mesh model, manufacturer, catalog number, and lot number
• Medical imaging and diagnostic findings
• Records documenting infection, obstruction, or recurrence
• Revision surgery or mesh removal records
• Pathology reports involving removed material
• Medical expenses and employment records

Patients can request implant-identification information from their surgeon or surgical facility. The FDA also provides guidance concerning medical device problem reporting through MedWatch [12].

What Compensation May Be Available?

Potential damages in a qualifying surgical mesh case may include medical expenses, revision surgery costs, future treatment, lost income, reduced earning capacity, pain and suffering, and other legally recognized losses.

Serious complications may require repeated operations or long-term medical care. Compensation amounts vary by case. Past results do not guarantee future outcomes.

Speak With an Aspide Surgimesh Lawyer

If you or a loved one developed serious complications after Surgimesh implantation, a product-liability attorney can review the surgical records, device identification, and medical findings. A free case review can help determine whether the available evidence and applicable law support a potential injury claim.

How Does an Aspide Surgimesh Lawsuit Work?

1. Free case review. An attorney examines the implant, medical history, injuries, and available documentation.
2. Investigation. Evidence may include FDA records, operative reports, implant identifiers, medical testing, and expert evaluations.
3. Filing. If supported by the evidence and applicable law, legal proceedings may be initiated against potentially responsible parties.
4. Discovery/negotiation. The parties may exchange evidence, evaluate medical causation, consult experts, and discuss settlement.
5. Resolution. A claim may conclude through settlement, dismissal, court ruling, or trial.

Frequently Asked Questions

What is the Aspide Surgimesh Lawsuit?

The Aspide Surgimesh Lawsuit refers to potential product-liability claims alleging injuries involving Surgimesh surgical implants. Federal court records document individual litigation, but those allegations do not automatically establish manufacturer liability.

What is Aspide Surgimesh made from?

Surgimesh WN is a nonwoven polypropylene surgical mesh, while XB incorporates polypropylene reinforcement with a silicone barrier. Other Surgimesh configurations have separate regulatory clearances and product specifications.

Was Aspide Surgimesh recalled?

Yes. Four specific Surgimesh WN and XB product lots were recalled over possible residual adhesive material, with FDA records posted in June 2025.

What complications are associated with hernia mesh?

Potential complications include chronic pain, infection, adhesions, bowel obstruction, mesh migration, contraction, and recurrence. These risks apply to hernia repair and surgical mesh generally, not exclusively to Surgimesh.

Did the FDA ban surgical mesh?

No. The FDA’s 2019 sales restriction concerned transvaginal mesh used for pelvic-organ-prolapse repair, not surgical mesh used for hernia repair generally.

Can I file an Aspide Surgimesh Lawsuit?

A patient with a documented injury following Surgimesh implantation may have a potential claim if the evidence and applicable law support liability. Eligibility depends on device identification, causation, damages, and filing deadlines.

Is there an Aspide Surgimesh settlement?

The reviewed federal records establish individual Surgimesh litigation but do not identify a nationwide Aspide Surgimesh settlement program. Any particular case outcome or settlement requires verification through current court records.

References

1. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=214051
2. https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_Actions_Pending-September-1-2026.pdf
3. https://www.fda.gov/medical-devices/implants-and-prosthetics/surgical-mesh-used-hernia-repair
4. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=214054
5. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=214053
6. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=214052
7. https://www.govinfo.gov/content/pkg/USCOURTS-casd-3_19-cv-00871/pdf/USCOURTS-casd-3_19-cv-00871-0.pdf
8. https://www.fda.gov/medical-devices/implants-and-prosthetics/urogynecologic-surgical-mesh-implants
9. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K061445
10. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K072974
11. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K092233
12. https://www.fda.gov/medical-devices/surgical-mesh-used-hernia-repair/surgical-mesh-used-hernia-repair-reporting-problems-fda